THE GABELLI HEALTHCARE & WELLNESSRx TRUST SALES AGREEMENT $62,500,000 value ofSales Agreement • January 10th, 2018 • Gabelli Healthcare & WellnessRx Trust • New York
The Gabelli Healthcare & WellnessRx Trust (the “Fund”), a statutory trust organized and existing under and by virtue of the laws of the State of Delaware, proposes to issue and sell through G.research, LLC (the “Sales Manager”), as agent, as much as $62,500,000 aggregate value (the “Maximum Amount”) of 5.875% Series B Cumulative Preferred Shares, par value $0.001 per share (the “Preferred Shares”), of the Fund. The Preferred Shares are classified and designated by the Fund’s Board of Trustees (the “Board”) pursuant to authority expressly vested in it by the Fund’s Declaration of Trust, as amended (the “Declaration of Trust”), and subject to the terms and conditions of the Statement of Preferences of the Fund’s 5.875% Series B Cumulative Preferred Shares, as amended (the “Statement”)
